CDKN2A and neoplasm: More specifically, of the 36/39 (92%) patients selected for surgery due to FDG PET-CT criteria, 35 had HPV-DNA-positive and p16+ tumours, while the remaining patient had an HPV-DNA-positive, but p16− tumour.